• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从海藻代谢产物中鉴定潜在的抗结核药物靶点:一种基于计算机的方法。

Identification of the Seaweed Metabolites as Potential Anti-tubercular Agents Against Human Pantothenate synthetase: An In Silico Approach.

机构信息

Centre for Drug Discovery and Development, Sathyabama Institute of Science and Technology, Jeppiaar Nagar, Rajiv Gandhi Road, Chennai, 600119, India.

ICAR-Central Institute of Brackishwater Aquaculture, Indian Council of Agricultural Research, Chennai, 600028, India.

出版信息

Curr Microbiol. 2023 Aug 14;80(10):318. doi: 10.1007/s00284-023-03422-w.

DOI:10.1007/s00284-023-03422-w
PMID:37578562
Abstract

Tuberculosis is the disease which is caused due to the contagion of Mycobacterium tuberculosis. The multidrug resistance Mycobacterium tuberculosis is the main hassle in the treatment of this worldwide health threats. Pantothenate synthase is a legitimate goal for rational drug designing against Mycobacterium tuberculosis. The enzyme is most active in the presence of magnesium or manganese. Marine algal cell wall is rich in sulfated polysaccharides such as fucoidans (brown algae), κ-carrageenans (red algae), and ulvan (green algae) with various favorable biological activities such as anticoagulant, antiviral, antioxidative, anticancer, and immunomodulating activities. In this study, we have modeled binding modes of selected known anti-tubercular compounds and different solvent extract against pantothenate synthase using advanced docking program AutoDock 4.2 tool. In our current study, in silico experiments were carried out to determine if fucoidan, κ-carrageenan, and ulvan sulfated polysaccharides could be a potential target against PANc (pantothenate synthetase), with the goal of identifying potential inhibitors as anti-TB leads targeting PANc for further wet lab validation. Two bioactive compounds were docked to the Mtb pantothenate synthetase protein binding site, with docking scores ranging from - 5.57 to - 2.73. κ-carrageenan had the best pose and docking score, with a Ligand fit score of - 5.815. Ulvan did not dock with the protein. The molecular dynamics simulations were conducted with substrate and ligand bounded fucoidan and κ-carrageenan for 150 ns and the protein Mtb pantothenate synthetase showed a stable conformation in the simulation, with tight amino acid contributions binding to the ligand molecule. RMSD characterizes the conformation and stability of protein ligand complexes, with higher fluctuations indicating low stability and minimal low-level fluctuations indicating equilibration and stability. The graph for RMSF shows significant peaks due to fluctuations in active site regions and other peaks indicating the adaptation of the ligand molecule to the protein binding pocket. From the molecular dynamics study, it is clear that the compounds are having good binding affinity in the active site. The root mean square deviation, root mean square fluctuations, and radius of gyration are supportive evidences which helped us to conclude that the compounds κ-carrageenan and fucoidan are suitable lead molecules for inhibiting pantothenate synthetase. Based on these evidences, the natural compounds from seaweeds can be tested clinically either alone or in combinations against the protein, which could facilitate the designing or the synthesis of new lead molecules as drugs against the tuberculosis.

摘要

结核病是由结核分枝杆菌感染引起的疾病。耐多药结核分枝杆菌是治疗这种全球健康威胁的主要障碍。泛酸合酶是针对结核分枝杆菌进行合理药物设计的合理目标。该酶在镁或锰存在下最活跃。海洋藻类细胞壁富含硫酸多糖,如褐藻中的褐藻糖胶、红藻中的 κ-卡拉胶和绿藻中的岩藻聚糖,具有多种有利的生物活性,如抗凝、抗病毒、抗氧化、抗癌和免疫调节活性。在这项研究中,我们使用先进的对接程序 AutoDock 4.2 工具对选定的已知抗结核化合物和不同溶剂提取物与泛酸合酶的结合模式进行了建模。在我们目前的研究中,进行了计算机模拟实验以确定褐藻糖胶、κ-卡拉胶和岩藻聚糖硫酸多糖是否可以成为 PANc(泛酸合酶)的潜在靶点,目标是确定潜在的抑制剂作为针对 PANc 的抗结核先导物,进一步通过湿实验室验证。两种生物活性化合物与 Mtb 泛酸合酶蛋白结合位点对接,对接评分范围为-5.57 至-2.73。κ-卡拉胶具有最佳构象和对接评分,配体拟合评分为-5.815。岩藻聚糖未与蛋白质对接。对底物和配体结合的褐藻糖胶和 κ-卡拉胶进行了 150ns 的分子动力学模拟,Mtb 泛酸合酶蛋白在模拟中表现出稳定的构象,与配体分子紧密结合的氨基酸贡献。RMSD 描述了蛋白质配体复合物的构象和稳定性,较高的波动表明稳定性低,较低的低水平波动表明平衡和稳定性。RMSF 图显示由于活性位点区域的波动而出现明显的峰,以及其他表明配体分子适应蛋白质结合口袋的峰。从分子动力学研究中可以清楚地看出,这些化合物在活性位点具有良好的结合亲和力。均方根偏差、均方根波动和回转半径是支持性证据,有助于我们得出结论,化合物 κ-卡拉胶和褐藻糖胶是抑制泛酸合酶的合适先导分子。基于这些证据,可以单独或组合使用来自海藻的天然化合物对该蛋白进行临床测试,这有助于设计或合成针对结核病的新型先导药物。

相似文献

1
Identification of the Seaweed Metabolites as Potential Anti-tubercular Agents Against Human Pantothenate synthetase: An In Silico Approach.从海藻代谢产物中鉴定潜在的抗结核药物靶点:一种基于计算机的方法。
Curr Microbiol. 2023 Aug 14;80(10):318. doi: 10.1007/s00284-023-03422-w.
2
Sulfated Seaweed Polysaccharides as Multifunctional Materials in Drug Delivery Applications.硫酸化海藻多糖作为药物递送应用中的多功能材料
Mar Drugs. 2016 Feb 25;14(3):42. doi: 10.3390/md14030042.
3
Identification of new benzamide inhibitor against α-subunit of tryptophan synthase from Mycobacterium tuberculosis through structure-based virtual screening, anti-tuberculosis activity and molecular dynamics simulations.通过基于结构的虚拟筛选、抗结核活性和分子动力学模拟,鉴定新型苯甲酰胺抑制剂对结核分枝杆菌色氨酸合酶α亚基的抑制作用。
J Biomol Struct Dyn. 2019 Mar;37(4):1043-1053. doi: 10.1080/07391102.2018.1448303. Epub 2018 Mar 13.
4
Novel pyrazine based anti-tubercular agents: Design, synthesis, biological evaluation and in silico studies.新型吡嗪类抗结核药物的设计、合成、生物评价及计算机模拟研究。
Bioorg Chem. 2020 Mar;96:103610. doi: 10.1016/j.bioorg.2020.103610. Epub 2020 Jan 25.
5
Identification of glucosyl-3-phosphoglycerate phosphatase as a novel drug target against resistant strain of Mycobacterium tuberculosis (XDR1219) by using comparative metabolic pathway approach.通过比较代谢途径方法鉴定葡萄糖-3-磷酸甘油酸磷酸酶作为抗多药耐药结核分枝杆菌(XDR1219)的新型药物靶标。
Comput Biol Chem. 2019 Apr;79:91-102. doi: 10.1016/j.compbiolchem.2019.01.011. Epub 2019 Jan 24.
6
Identification of Concomitant Inhibitors against Glutamine Synthetase and Isocitrate Lyase in from Natural Sources.从天然产物中鉴定谷氨酰胺合成酶和异柠檬酸裂解酶的同时抑制剂。
Biomed Res Int. 2022 Oct 3;2022:4661491. doi: 10.1155/2022/4661491. eCollection 2022.
7
A comparative modeling and molecular docking study on Mycobacterium tuberculosis targets involved in peptidoglycan biosynthesis.关于参与肽聚糖生物合成的结核分枝杆菌靶点的比较建模和分子对接研究。
J Biomol Struct Dyn. 2016 Nov;34(11):2399-417. doi: 10.1080/07391102.2015.1117397. Epub 2016 Apr 4.
8
Unearthing phytochemicals as natural inhibitors for pantothenate synthetase in : A computational approach.挖掘植物化学物质作为泛酸合成酶的天然抑制剂:一种计算方法。
Front Pharmacol. 2024 Jul 29;15:1403900. doi: 10.3389/fphar.2024.1403900. eCollection 2024.
9
A multidrug efflux protein in Mycobacterium tuberculosis; tap as a potential drug target for drug repurposing.结核分枝杆菌中的一种多药外排蛋白;缬更昔洛韦可作为药物再利用的潜在药物靶点。
Comput Biol Med. 2022 Jul;146:105607. doi: 10.1016/j.compbiomed.2022.105607. Epub 2022 May 16.
10
Lead identification against using highly enriched active molecules against pantothenate synthetase.针对泛酸合成酶使用高度富集的活性分子进行先导化合物鉴定。
J Biomol Struct Dyn. 2024;42(20):11080-11097. doi: 10.1080/07391102.2023.2260483. Epub 2023 Sep 25.

引用本文的文献

1
Unearthing phytochemicals as natural inhibitors for pantothenate synthetase in : A computational approach.挖掘植物化学物质作为泛酸合成酶的天然抑制剂:一种计算方法。
Front Pharmacol. 2024 Jul 29;15:1403900. doi: 10.3389/fphar.2024.1403900. eCollection 2024.

本文引用的文献

1
Clinical Evaluation of the XDR-LFC Assay for the Molecular Detection of Isoniazid, Rifampin, Fluoroquinolone, Kanamycin, Capreomycin, and Amikacin Drug Resistance in a Prospective Cohort.XDR-LFC 法在一个前瞻性队列中对异烟肼、利福平、氟喹诺酮类、卡那霉素、卷曲霉素和阿米卡星耐药性的分子检测的临床评估。
J Clin Microbiol. 2023 Mar 23;61(3):e0147822. doi: 10.1128/jcm.01478-22. Epub 2023 Feb 9.
2
Tuberculosis in individuals who recovered from COVID-19: A systematic review of case reports.COVID-19 康复者中的结核病:病例报告的系统评价。
PLoS One. 2022 Nov 28;17(11):e0277807. doi: 10.1371/journal.pone.0277807. eCollection 2022.
3
Bedaquiline: A Novel Diarylquinoline for Multidrug-Resistant Pulmonary Tuberculosis.
贝达喹啉:一种用于耐多药肺结核的新型二芳基喹啉。
Cureus. 2022 Aug 29;14(8):e28519. doi: 10.7759/cureus.28519. eCollection 2022 Aug.
4
Immune evasion and provocation by Mycobacterium tuberculosis.结核分枝杆菌的免疫逃逸和免疫激发。
Nat Rev Microbiol. 2022 Dec;20(12):750-766. doi: 10.1038/s41579-022-00763-4. Epub 2022 Jul 25.
5
Inhibitors of pantothenate synthetase of - a medicinal chemist perspective.泛酸合成酶抑制剂——药物化学家的视角
RSC Adv. 2020 Oct 7;10(61):37098-37115. doi: 10.1039/d0ra07398a.
6
Screening approaches and therapeutic targets: The two driving wheels of tuberculosis drug discovery.筛查方法和治疗靶点:结核病药物发现的两个推动轮。
Biochem Pharmacol. 2022 Mar;197:114906. doi: 10.1016/j.bcp.2021.114906. Epub 2022 Jan 4.
7
Ten simple rules on how to create open access and reproducible molecular simulations of biological systems.关于如何创建生物系统的开放获取且可重现分子模拟的十条简单规则。
PLoS Comput Biol. 2019 Jan 17;15(1):e1006649. doi: 10.1371/journal.pcbi.1006649. eCollection 2019 Jan.
8
Current status and research strategies in tuberculosis drug development.结核病药物研发的现状与研究策略
J Med Chem. 2011 Sep 22;54(18):6157-65. doi: 10.1021/jm200305q. Epub 2011 Aug 16.
9
Lead finder: an approach to improve accuracy of protein-ligand docking, binding energy estimation, and virtual screening.铅离子寻找器:一种提高蛋白质-配体对接、结合能估计和虚拟筛选准确性的方法。
J Chem Inf Model. 2008 Dec;48(12):2371-85. doi: 10.1021/ci800166p.
10
Molecular field extrema as descriptors of biological activity: definition and validation.作为生物活性描述符的分子场极值:定义与验证
J Chem Inf Model. 2006 Mar-Apr;46(2):665-76. doi: 10.1021/ci050357s.